60 Degrees Pharmaceuticals, Inc.

Total Valuation

60 Degrees Pharmaceuticals, Inc. carries a market capitalization of 3.02M, placing it among publicly traded companies globally. Its enterprise value stands at 13.29M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

60 Degrees Pharmaceuticals, Inc. currently has 2.66M shares outstanding.

Valuation Ratios

The price-to-sales ratio is 2.80, and the price-to-book ratio stands at -0.67.

Enterprise Valuation

Financial Position

60 Degrees Pharmaceuticals, Inc. maintains a current ratio of 2.32, meaning it holds 2.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 5.98, indicating elevated leverage, while an interest coverage ratio of -1,121.26 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Taxes

Stock Price Statistics

60 Degrees Pharmaceuticals, Inc.'s stock has declined approximately -85.66667% over the past 52 weeks. The 50-day moving average sits at 1.06, while the 200-day moving average is 1.83.

Income Statement

Over the trailing twelve months, 60 Degrees Pharmaceuticals, Inc. generated 1.11M in revenue and converted that into -8.11M in net income, yielding earnings per share of -4.59. EBITDA reached -8.51M, while operating income came in at -8.61M.

Balance Sheet

60 Degrees Pharmaceuticals, Inc. holds 1.02M in cash and equivalents against 151,179.00 in total debt, resulting in a net debt position of -871,427.00. Total book value stands at -6.95M, with working capital of 2.13M providing operational flexibility.

Cash Flow

60 Degrees Pharmaceuticals, Inc. produced -8.77M in operating cash flow over the past twelve months. After subtracting -206,926.00 in capital expenditures, free cash flow totaled -8.98M - equivalent to -5.09 per share.

Margins

60 Degrees Pharmaceuticals, Inc. operates with a gross margin of 19.42, reflecting its pricing power and cost economics. The operating margin of -774.90 and net profit margin of -729.86 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

60 Degrees Pharmaceuticals, Inc.'s most recent stock split took place on January 20, 2026 with a 4:1 split ratio.

Scores

60 Degrees Pharmaceuticals, Inc. posts an Altman Z-Score of -23.03, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.